CP
BIIB icon

CenterBook Partners’s Biogen BIIB Stock Holding History

CenterBook Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,987
Closed -$5.81M – 476
2024
Q3 		$5.81M Sell
29,987
-26,841
-47% -$5.62M 0.36% 83
2024
Q2 		$13.2M Buy
56,828
+52,863
+1,333% +$11.5M 0.82% 11
2024
Q1 		$855K Buy
3,965
+657
+20% +$154K 0.06% 321
2023
Q4 		$856K Buy
+3,308
New +$813K 0.1% 273
2022
Q4 		– Sell
-1,726
Closed -$461K – 389
2022
Q3 		$461K Sell
1,726
-199
-10% -$42.3K 0.09% 290
2022
Q2 		$393K Sell
1,925
-1,111
-37% -$227K 0.08% 295
2022
Q1 		$639K Sell
3,036
-81
-3% -$17.6K 0.23% 163
2021
Q4 		$748K Buy
+3,117
New +$801K 0.44% 72

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CenterBook Partners's BIIB Position: Q4 2024 in Review

CenterBook Partners sold out of Biogen (BIIB) in Q4 2024, closing a stake of 29,987 shares — an estimated $5.81M sold.

CenterBook Partners first reported a position in BIIB in Q4 2021 and held it in 8 quarters. The position peaked at $13.2M in Q2 2024. 874 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • CenterBook Partners reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • CenterBook Partners sold 29,987 Biogen shares in Q4 2024, an estimated $5.81M.
  • CenterBook Partners first reported a position in Biogen in Q4 2021 and held it in 8 quarters.
  • CenterBook Partners's Biogen position peaked at $13.2M in Q2 2024.
  • 874 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on CenterBook Partners's 13F filing for Q4 2024, filed 13 Feb 2025.